IP Library Patent Application 16641911
Patent Application
App. No. 16/641,911

METHOD AND KIT FOR DETECTING HEPATITIS B SURFACE ANTIGEN

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/641,911
Abstract

The present invention pertains to a method for detecting HBsAg with which it is possible to detect HBsAg with high sensitivity even when blood (whole blood) is used as a sample. A sample is provided on a metal film on the surface of which there is immobilized a binding substance (e.g., an antibody) capable of specifically binding to hepatitis B surface antigens, and hepatitis B surface antigens included in the sample are bound by the binding substance. The hepatitis B surface antigens are also labeled by a fluorescent substance. Fluorescence, which is emitted from the fluorescent substance when the metal film is irradiated with excitation light so that surface plasmon resonance is produced in the metal film, is detected.

Claims (28)

1 . A detection method for a hepatitis B virus surface antigen, comprising:

preparing a detection chip including a metal film and a binding substance which is immobilized on the metal film and which specifically binds to a hepatitis B virus surface antigen;

providing a specimen onto the metal film to cause a hepatitis B virus surface antigen contained in the specimen to bind to the binding substance;

labeling, with a fluorescent substance, the hepatitis B virus surface antigen before or after binding to the binding substance; and

detecting fluorescence emitted from the fluorescent substance when the metal film is irradiated with excitation light in such a manner as to generate surface plasmon resonance in the metal film with the hepatitis B virus surface antigen labeled with the fluorescent substance kept in a state binding to the binding substance.

2 . The detection method for a hepatitis B virus surface antigen according to claim 1 , wherein the hepatitis B virus surface antigen is labeled with the fluorescent substance through binding to a binding substance specifically binding to a hepatitis B virus surface antigen and having been labeled with the fluorescent substance.

3 . The detection method for a hepatitis B virus surface antigen according to claim 2 , wherein the binding substance immobilized on the metal film and the binding substance labeled with the fluorescent substance are both anti-hepatitis B virus surface antigen antibodies.

4 . The detection method for a hepatitis B virus surface antigen according to claim 3 ,

wherein the anti-hepatitis B virus surface antigen antibody immobilized on the metal film is one or two or more anti-hepatitis B virus surface antigen monoclonal antibodies or anti-hepatitis virus surface antigen polyclonal antibodies, and

the anti-hepatitis B virus surface antigen antibody labeled with the fluorescent substance is one or two or more anti-hepatitis B virus surface antigen monoclonal antibodies or anti-hepatitis B virus surface antigen polyclonal antibodies different from the anti-hepatitis B virus surface antigen antibody immobilized on the metal film.

5 . The detection method for a hepatitis B virus surface antigen according to claim 3 , wherein the anti-hepatitis B virus surface antigen antibody immobilized on the metal film and the anti-hepatitis B virus surface antigen antibody labeled with the fluorescent substance are both antibodies binding to an S region of the hepatitis B virus surface antigen.

6 . The detection method for a hepatitis B virus surface antigen according to claim 3 , wherein the anti-hepatitis B virus surface antigen antibody immobilized on the metal film and the anti-hepatitis B virus surface antigen antibody labeled with the fluorescent substance both include both of an antibody binding to an S region of the hepatitis B virus surface antigen and an antibody binding to a Pre-S2 region of the hepatitis B virus surface antigen.

7 . The detection method for a hepatitis B virus surface antigen according to claim 3 , wherein the fluorescent substance binds to the anti-hepatitis B virus surface antigen antibody via an amino group or a sulfhydryl group of the anti-hepatitis B virus surface antigen antibody.

8 . The detection method for a hepatitis B virus surface antigen according to claim 1 , wherein the specimen is blood.

9 . The detection method for a hepatitis B virus surface antigen according to claim 1 ,

wherein the metal film is disposed on a prism, and

the metal film is irradiated with the excitation light through the prism.

10 . The detection method for a hepatitis B virus surface antigen according to claim 1 ,

wherein the metal film includes a diffraction grating,

the binding substance is immobilized on the diffraction grating, and

the diffraction grating is irradiated with the excitation light.

11 . The detection method for a hepatitis B virus surface antigen according to claim 1 , wherein the excitation light is laser light emitted from a laser light source having an output power of 15 to 30 mW.

12 . A detection kit for a hepatitis B virus surface antigen, comprising:

a detection chip including a metal film and a binding substance which is immobilized on the metal film and which specifically binds to a hepatitis B virus surface antigen; and

a labeling reagent for labeling a hepatitis B virus surface antigen with a fluorescent substance.

13 . The detection kit for a hepatitis B virus surface antigen according to claim 12 ,

wherein the labeling reagent is a binding substance specifically binding to a hepatitis B virus surface antigen and having been labeled with a fluorescent substance.

14 . The detection kit for a hepatitis B virus surface antigen according to claim 13 , wherein the binding substance immobilized on the metal film and the binding substance labeled with the fluorescent substance are both anti-hepatitis B virus surface antigen antibodies.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 21, 2022
From: KONICA MINOLTA, INC.
To: OTSUKA PHARMACEUTICAL CO., LTD.
Reel/Frame 059747/0589 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2020
From: TERADA, KOTARO
To: KONICA MINOLTA, INC.
Reel/Frame 051923/0934 →